We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS Recalls Avalide Lots for Solubility Issue
BMS Recalls Avalide Lots for Solubility Issue
February 10, 2011
Bristol-Myers Squibb (BMS) is recalling lots of its hypertension drug Avalide due to small quantities of a less-soluble form of the active ingredient.